Eileen McPartland Joins Allscripts as Chief Operating Officer

Former Oracle, SAP and Misys executive brings extensive software technology
operations experience

CHICAGO, June 1 /PRNewswire-FirstCall/ -- Allscripts announced today that
Eileen McPartland has joined the company as Chief Operating Officer. Ms.
McPartland brings to the position extensive operational experience from senior
leadership roles within some of the world's best-known technology software and
services companies.

Ms. McPartland was most recently Executive Vice President of Global Sales and
Services for Misys plc (FTSE: MSY.L), the global applications software and
services company, where she was responsible for directing all customer-facing
activities and over 2,500 people. She played a key role in delivering the
Misys turnaround, implementing world-class processes and driving the
transformation that helped to return Misys to a growth company.

"We are very excited that Eileen is joining Allscripts, building on our solid
performance during the past year," said Glen Tullman, Chief Executive Officer
of Allscripts. "Her exemplary leadership, focus on operational excellence, and
broad knowledge of the healthcare industry and of Allscripts will help ensure
that we continue to deliver world-class client service while preparing to meet
what we expect will be significant growth in demand for electronic health
record solutions in the next few years."

Prior to joining Misys in January 2007, Ms. McPartland was Senior Vice
President, North America Consulting, at Oracle. In that position, she held
responsibility for Oracle's application, technology and Indian offshore
consulting practices. From 1994 to 1998, Ms. McPartland held the position of
Executive Vice President at SAP America, where she helped grow revenues from
$100 million to over $1 billion.

Ms. McPartland joins Allscripts at a time when demand for the company's
solutions and services is likely to significantly increase in response to a
new federal "economic stimulus" package that provides a maximum of between
$44,000 and $64,000 in incentives for physicians to adopt and use Electronic
Health Records. The American Recovery and Reinvestment Act of 2009 provides
for the incentives over five years, beginning in fiscal 2011, for physicians
who demonstrate meaningful use of a certified EHR system.

"I am excited to join the senior leadership team of Allscripts, the clear
leader in healthcare information technology and the company best placed to
help physicians benefit from the federal stimulus package by connecting their
practices with our broad suite of industry leading solutions," said Ms.
McPartland. "I'm excited to put my experience to work helping the Company and
our clients maximize the value of our solutions while taking full advantage of
the Stimulus dollars available."

Ms. McPartland will assume the duties of Chief Operating Officer from Lee
Shapiro, who will continue in his role as President. Mr. Shapiro, who has been
President of Allscripts since 2000, has held the interim COO position since
October 2008. Mr. Shapiro will continue leading the company's strategy,
mergers and acquisitions, business development, emerging businesses and
strategic partnerships.

"I am looking forward to partnering with Eileen on the significant business
opportunities in front of Allscripts," said Mr. Shapiro.

Ms. McPartland and Mr. Shapiro will both report directly to Mr. Tullman.

About Allscripts
Allscripts (Nasdaq: MDRX) uses innovation technology to bring health to
healthcare. More than 150,000 physicians, 700 hospitals and nearly 7,000
post-acute and homecare organizations utilize Allscripts to improve the health
of their patients and their bottom line. The company's award-winning solutions
include electronic health records, electronic prescribing, revenue cycle
management, practice management, document management, medication services,
hospital care management, emergency department information systems and
homecare automation. Allscripts is the brand name of Allscripts-Misys
Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.

This news release may contain forward-looking statements within the meaning of
the federal securities laws. Statements regarding future events, developments,
the Company's future performance, as well as management's expectations,
beliefs, intentions, plans, estimates or projections relating to the future
are forward-looking statements within the meaning of these laws. These
forward-looking statements are subject to a number of risks and uncertainties,
some of which are outlined below. As a result, actual results may vary
materially from those anticipated by the forward-looking statements. Among the
important factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are: the volume and timing
of systems sales and installations; length of sales cycles and the
installation process; the possibility that products will not achieve or
sustain market acceptance; the timing, cost and success or failure of new
product and service introductions, development and product upgrade releases;
competitive pressures including product offerings, pricing and promotional
activities; our ability to establish and maintain strategic relationships;
undetected errors or similar problems in our software products; compliance
with existing laws, regulations and industry initiatives and future changes in
laws or regulations in the healthcare industry; possible regulation of the
Company's software by the U.S. Food and Drug Administration; the possibility
of product-related liabilities; our ability to attract and retain qualified
personnel; our ability to identify and complete acquisitions, manage our
growth and integrate acquisitions; the ability to recognize the benefits of
the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS
with the Company and the possible disruption of current plans and operations
as a result thereof; maintaining our intellectual property rights and
litigation involving intellectual property rights; risks related to
third-party suppliers; our ability to obtain, use or successfully integrate
third-party licensed technology; breach of our security by third parties; and
the risk factors detailed from time to time in our reports filed with the
Securities and Exchange Commission, including our 2007 Annual Report on Form
10-K available through the Web site maintained by the Securities and Exchange
Commission at www.sec.gov. The Company undertakes no obligation to update
publicly any forward-looking statement, whether as a result of new
information, future events or otherwise.

SOURCE Allscripts

Dan Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com, or Todd Stein, Senior Manager/Public Relations,
+1-312-506-1216, todd.stein@allscripts.com, both of Allscripts